Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04800822
Title PF-07284892 in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Pfizer
Indications

lung non-small cell carcinoma

colorectal cancer

Advanced Solid Tumor

Therapies

PF-07284892

Cetuximab + Encorafenib + PF-07284892

Lorlatinib + PF-07284892

Binimetinib + PF-07284892

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST